葡萄糖皮质体信号通路:从长椅到床边
Nicolas C Nicolaides1,2,3,4, George P Chrousos1,2,3
1Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, "Aghia Sophia" Children's Hospital, 11527 Athens, Greece.
International journal of molecular sciences
|July 14, 2023
概括
葡萄糖皮质类药物在葡萄糖代谢中起着关键作用,正如汉斯·雨果·布鲁诺·塞莱 (Hans Hugo Bruno Selye) 所指出的那样. 这些激素对于管理身体对压力的反应和维持能量平衡至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 代谢科学 代谢科学
背景情况:
- 葡萄糖皮质激素是一种类型的类固醇激素.
- 由汉斯·雨果·布鲁诺·塞莱命名,他是压力研究的先驱.
- 对于葡萄糖代谢和应激反应至关重要.
研究的目的:
- 探索葡萄糖皮质醇的历史背景和意义.
- 阐明它们在葡萄糖代谢中的作用.
- 了解它们与压力概念的联系.
主要方法:
- 历史科学贡献的文献评论.
- 对内分泌功能和代谢途径的分析.
- 关于压力和荷尔蒙调节的研究综合.
主要成果:
- 葡萄糖皮质类药物是葡萄糖平衡的组成部分.
- 它们的功能超出了新陈代谢的范围,到应激适应.
- 塞莱的工作确立了它们的基本重要性.
结论:
- 葡萄皮质皮质激素是具有多方面的作用的重要激素.
- 了解它们的功能是代谢和压力研究的关键.
- 历史背景为当前的科学理解提供了信息.
相关概念视频
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Insulin: The Receptor and Signaling Pathways
1.3K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.3K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
155
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
155
Chemical Signaling in the Endocrine System
3.3K
A signaling cascade is a series of events that facilitates the transmission of information within or between cells, culminating in a targeted response in the recipient cell. As chemical messengers, hormones are pivotal in initiating and modulating these intricate signaling cascades based on their solubility.
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
3.3K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Glucagon-like Receptor Agonists
364
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
364


